BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
3133 results:

  • 1. RICTOR/mTORC2 downregulation in BRAF
    Ponzone L; Audrito V; Landi C; Moiso E; Levra Levron C; Ferrua S; Savino A; Vitale N; Gasparrini M; Avalle L; Vantaggiato L; Shaba E; Tassone B; Saoncella S; Orso F; Viavattene D; Marina E; Fiorilla I; Burrone G; Abili Y; Altruda F; Bini L; Deaglio S; Defilippi P; Menga A; Poli V; Porporato PE; Provero P; Raffaelli N; Riganti C; Taverna D; Cavallo F; Calautti E
    Mol Cancer; 2024 May; 23(1):105. PubMed ID: 38755661
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Optimizing deep learning-based segmentation of densely packed cells using cell surface markers.
    Han S; Phasouk K; Zhu J; Fong Y
    BMC Med Inform Decis Mak; 2024 May; 24(1):124. PubMed ID: 38750526
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies.
    De Carli A; Kapelyukh Y; Kursawe J; Chaplain MAJ; Wolf CR; Hamis S
    NPJ Syst Biol Appl; 2024 May; 10(1):51. PubMed ID: 38750040
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery.
    Otto TS; Ragi SD; John AM; Bhatti H
    J Drugs Dermatol; 2024 May; 23(5):380. PubMed ID: 38709685
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Global burden and prediction study of cutaneous squamous cell carcinoma from 1990 to 2030: A systematic analysis and comparison with China.
    Huang S; Jiang J; Wong HS; Zhu P; Ji X; Wang D
    J Glob Health; 2024 May; 14():04093. PubMed ID: 38695259
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
    Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
    Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
    Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
    Roohani S; Ehret F; Beck M; Veltsista DP; Nadobny J; Zschaeck S; Abdel-Rahman S; Eckert F; Flörcken A; Issels RD; Klöck S; Krempien R; Lindner LH; Notter M; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Riesterer O; Spałek MJ; Stutz E; Wessalowski R; Zilli T; Zips D; Ghadjar P; Kaul D
    Int J Hyperthermia; 2024; 41(1):2342348. PubMed ID: 38653548
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature.
    Gjukaj D; Morina I; Valmaggia C; Ammann D; Todorova MG
    Klin Monbl Augenheilkd; 2024 Apr; 241(4):421-425. PubMed ID: 38653304
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Parameter-based transfer learning for severity classification of atopic dermatitis using hyperspectral imaging.
    Kim EB; Baek YS; Lee O
    Skin Res Technol; 2024 Apr; 30(4):e13704. PubMed ID: 38627927
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Applications of Data Characteristic AI-Assisted Raman Spectroscopy in Pathological Classification.
    Chen X; Shen J; Liu C; Shi X; Feng W; Sun H; Zhang W; Zhang S; Jiao Y; Chen J; Hao K; Gao Q; Li Y; Hong W; Wang P; Feng L; Yue S
    Anal Chem; 2024 Apr; 96(16):6158-6169. PubMed ID: 38602477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms.
    Xie J; Wu D; Zhang P; Zhao S; Qi M
    Exp Dermatol; 2024 Apr; 33(4):e15070. PubMed ID: 38570935
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Optimizing Ideal Thickness of Sections for Epidermis in Intra-Operative Frozen Sections.
    Dharmaraj K; Pandiar D; Krishnan RP
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):735-738. PubMed ID: 38546055
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
    Jeong H; Cho YR; Gim J; Cha SK; Kim M; Kang DR
    PLoS One; 2024; 19(3):e0291223. PubMed ID: 38536842
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
    Nakamura M; Yoshimitsu M; Magara T; Kano S; Kato H; Morita A
    Exp Dermatol; 2024 Mar; 33(3):e15062. PubMed ID: 38532566
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
    Paris J; Wilhelm C; Lebbé C; Elmallah M; Pamoukdjian F; Héraud A; Gapihan G; Walle AV; Tran VN; Hamdan D; Allayous C; Battistella M; Van Glabeke E; Lim KW; Leboeuf C; Roger S; Falgarone G; Phan AT; Bousquet G
    Clin Transl Med; 2024 Mar; 14(3):e1632. PubMed ID: 38515278
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Spectrum of malignant and premalignant skin lesions in 505 adult subjects at risk of skin cancers.
    Nevakivi R; Siiskonen H; Haimakainen S; Harvima IT
    BMC Cancer; 2024 Mar; 24(1):338. PubMed ID: 38486210
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
    Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
    Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 157.